Treatment for glioblastoma (GBM)
Intended for US audiences only.

Contact us

From your first question about Optune® and throughout your treatment, the nCompass team at Novocure provides customized support based on your needs.

For patient assistance, insurance questions, technical support, physician information, and general inquiries, please contact nCompass support by providing the information requested below.

Call us toll free, any time of day:
1-855-281-9301 (toll free)

We’re committed to providing answers and resources to help you meet your treatment goals.

We cannot provide you with medical advice. Consult with your doctor for medical related questions.

()
I am a patient/caregiver Other
By clicking here, I am agreeing to the statements below and confirm that I have read and accept Novocure’s Privacy Policy. I also affirm that I am at least eighteen (18) years of age or older. I authorize Novocure Inc. (Novocure), its affiliates, and companies working with Novocure to contact me by direct mail, email, telephone, and electronic message (including autodialed and pre-recorded calls and messages) for marketing purposes, such as: to keep me informed about products and patient support services; to provide me special offers regarding Novocure products and programs; to conduct market research or surveys; or other opportunities that may be of interest to me. I further understand that the information that I share with Novocure may be used by Novocure, its affiliates, and companies working with Novocure to develop future products, services, and programs. I understand that I may choose to no longer receive further communications from Novocure by following the unsubscribe instructions on the communication

*Indicates required field.

OPT-1605.8

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure™, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.


On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals.

What is Optune approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.